Connecting the Dots for Better Healthcare

SPB MIR Company is successfully carrying out export business of pharmaceutical products and chemicals since its establishment in 2010. During this time, our network has been built with leading pharmaceutical companies in CIS. Based upon this network, we are exporting number of high-quality Korean drugs to CIS market exclusively and we are taking part in global expansion of Korean pharmaceutical industry through export of pharmaceutical plant and technology transfer of IV solution manufacturing.

We are supplying APIs and finished products of various antibiotics and anti-tuberculosis drug to leading pharmaceutical companies in Russia such as Pharmstandard, R-Pharm, Kraspharm, Akrihin and Abolmed. Moreover, we won national tenders of Carbapenem antibiotic for the 4th consecutive year since 2009 in Belarus. Then, we succeeded an export of IV solution manufacturing plant which took place first time in the history of Korean pharmaceutical industry. Simultaneously, we are executing technology transfer project with Polpharma, multinational pharmaceutical company and Chimpharm, No.1 Kazakh pharmaceutical company. It brings forth development of new business field. Besides, in order to develop healthcare industry in other CIS countries, we are eagerly operating for introducing and supplying of quality products..

We are building CIS-focused, effective business structure based upon expertise and experiences for particularity of CIS. And also, we have strong operational potentials for entire pharmaceutical industry covering broad business scope from market research and to plant export. As a result, we are playing an important role for connecting pharmaceutical industries between CIS and Korea.

We will continue to grow to be trustworthy partner and to bring in new opportunities through ceaseless innovation and development in the midst of rapidly changing CIS market.